Mark Diamond, MD, PhD

Medical Oncology
Accepting new patients
Sees patients age 18 and up
Penn Hematology/Oncology Pennsylvania Hospital
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Washington University School of Medicine
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Diamond is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Diamond, MS, Lin, JH, Vonderheide, RH Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming , Cancer Immunol Res , 9(8): 2021,877-890

Vishruth K Reddy, Varsha Jain, Robert J Wilson Ii, Lee P Hartner, Mark Diamond, Ronnie A Sebro, Kristy L Weber, Robert G Maki, Jacob E Shabason Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database , Sarcoma , 13: 2021,1:9712070.

Morrison, AH, Diamond, MS, Hay, CA, Byrne, KT, Vonderheide, RH. Sufficiency of CD40 activate and immune checkpoint blockade for T cell priming and tumor immunity. , Proc Natl Acad Sci U S A , 117(14): 2020,8022-8031

Rebecca A Evans, Mark S Diamond, Andrew J Rech, Timothy Chao, Max W Richardson, Jeffrey H Lin, David L Bajor, Katelyn T Byrne, Ben Z Stanger, James L Riley, Nune Markosyan, Rafael Winograd, Robert H Vonderheide Lack of immunoediting in murine pancreatic cancer reversed with neoantigen , JCI Insight , 1(14): 2016,e88328.

Diamond, M., Gangadhar, T., Schuchter, L.M Immunotherapy for Melanoma. Abeloff’s Clinical Oncology Updates. , Elsevier : 2015

Mark S Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P Dunn, Jessica M Archambault, Hsiaoju Lee, Cora D Arthur, J Michael White, Ulrich Kalinke, Kenneth M Murphy, Robert D Schreiber Type I interferon is selectively required by dendritic cells for immune rejection of tumors , J Exp Med , 208(10): 2011,1989-2003

Kai Hildner, Brian T Edelson, Whitney E Purtha, Mark Diamond, Hirokazu Matsushita, Masako Kohyama, Boris Calderon, Barbara U Schraml, Emil R Unanue, Michael S Diamond, Robert D Schreiber, Theresa L Murphy, Kenneth M Murphy Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity , Science , 322(5904): 2008,1097-100

Kathleen C F Sheehan, Koon Siew Lai, Gavin P Dunn, Allen T Bruce, Mark S Diamond, Jennifer D Heutel, Corazon Dungo-Arthur, Javier A Carrero, J Michael White, Paul J Hertzog, Robert D Schreiber Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection , J Interferon Cytokine Res , 26(11): 2006,804-19

Gavin P Dunn, Allen T Bruce, Kathleen C F Sheehan, Vijay Shankaran, Ravindra Uppaluri, Jack D Bui, Mark S Diamond, Catherine M Koebel, Cora Arthur, J Michael White, Robert D Schreiber A critical function for type I interferons in cancer immunoediting , Nat Immunol , 6(7): 2005,722-9